五洲医疗
(301234)
| 流通市值：50.68亿 | | | 总市值：85.48亿 |
| 流通股本：4031.80万 | | | 总股本：6800.00万 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 300,169,207.11 | 203,045,041.05 | 100,616,784.24 | 458,282,116.04 |
| 营业收入 | 300,169,207.11 | 203,045,041.05 | 100,616,784.24 | 458,282,116.04 |
| 二、营业总成本 | 288,854,890.71 | 192,762,378.66 | 95,348,895.49 | 441,702,032.61 |
| 营业成本 | 248,961,177.19 | 166,337,256.51 | 83,067,452.9 | 391,482,291.47 |
| 税金及附加 | 2,470,387.28 | 1,778,485.39 | 973,472.64 | 3,915,165.85 |
| 销售费用 | 11,414,786 | 7,886,746.43 | 3,591,216.86 | 18,222,120.67 |
| 管理费用 | 14,087,265.38 | 8,541,386.97 | 3,681,789.6 | 19,517,733.19 |
| 研发费用 | 6,859,931.17 | 4,483,208.32 | 2,043,691.55 | 9,741,167.79 |
| 财务费用 | 5,061,343.69 | 3,735,295.04 | 1,991,271.94 | -1,176,446.36 |
| 其中:利息费用 | 6,775.56 | 3,619.25 | 1,528.14 | 18,833.43 |
| 其中:利息收入 | 664,932.02 | 491,830.33 | 293,931.91 | 2,437,352.39 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 473,533.93 | 95,352.13 | 62,384.32 | -239,735.29 |
| 加:投资收益 | 4,146,482.82 | 2,931,006.39 | 1,230,871.23 | 5,521,436.77 |
| 资产处置收益 | 606,508.63 | 606,508.63 | 414,119.47 | -27,064.71 |
| 资产减值损失(新) | -3,076,164.45 | -1,854,506.43 | -1,538,191.07 | -2,708,572.21 |
| 信用减值损失(新) | 1,058,122.87 | 547,700.32 | 238,329.86 | 1,161,536.11 |
| 其他收益 | 6,279,187.16 | 4,859,270.22 | 3,575,141.67 | 3,233,535.19 |
| 四、营业利润 | 20,801,987.36 | 17,467,993.65 | 9,250,544.23 | 23,521,219.29 |
| 加:营业外收入 | 133,896.38 | 55,237.55 | 13,052.53 | 74,239 |
| 减:营业外支出 | 491,317.33 | 163,724.95 | 78,518.43 | 702,241.48 |
| 五、利润总额 | 20,444,566.41 | 17,359,506.25 | 9,185,078.33 | 22,893,216.81 |
| 减:所得税费用 | 2,911,918.4 | 1,996,135.46 | 1,134,096.88 | 4,000,195.23 |
| 六、净利润 | 17,532,648.01 | 15,363,370.79 | 8,050,981.45 | 18,893,021.58 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 17,532,648.01 | 15,363,370.79 | 8,050,981.45 | 18,893,021.58 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 17,532,648.01 | 15,363,370.79 | 8,050,981.45 | 18,893,021.58 |
| 扣除非经常损益后的净利润 | 11,198,253.47 | 10,904,884.54 | 5,157,453.69 | 14,410,635.17 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.26 | 0.23 | 0.12 | 0.28 |
| (二)稀释每股收益 | 0.26 | 0.23 | 0.12 | 0.28 |
| 九、综合收益总额 | 17,532,648.01 | 15,363,370.79 | 8,050,981.45 | 18,893,021.58 |
| 归属于母公司股东的综合收益总额 | 17,532,648.01 | 15,363,370.79 | 8,050,981.45 | 18,893,021.58 |
| 公告日期 | 2026-10-23 | 2026-08-24 | 2026-04-23 | 2026-04-23 |
| 审计意见(境内) | | | | 标准无保留意见 |